Wendy F Dicicco's Net Worth
$588 Million
Who is Wendy F Dicicco?
Wendy F Dicicco has an estimated net worth of $588 Million. This is based on reported shares across multiple companies, which include CANNAPHARMARX, INC., SWK Holdings Corp, II-VI INC, EyePoint Pharmaceuticals, Inc., Renovacor, Inc., KENSEY NASH CORP, and Akari Therapeutics Plc.
SEC CIK
Wendy F Dicicco's CIK is 0001225165
Past Insider Trading and Trends
2022 was Wendy F Dicicco's most active year for acquiring shares with 13 total transactions. Wendy F Dicicco's most active month to acquire stocks was the month of July. 2008 was Wendy F Dicicco's most active year for disposing of shares, totalling 29 transactions. Wendy F Dicicco's most active month to dispose stocks was the month of May. 2008 saw Wendy F Dicicco paying a total of $592,012.70 for 48,000 shares, this is the most they've acquired in one year. In 2008 Wendy F Dicicco cashed out on 62,050 shares for a total of $1,069,991.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CANNAPHARMARX, INC. (CPMD) Snapshot price: $0.012631
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SWK Holdings Corp (SWKH) Snapshot price: $17.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.34% | 1.9K |
$17.64 | $33,498.36 | 6.18K |
Dec 30
| |||
Form 4
| +85.25% | 1.97K |
$17.00 | $33,507.00 | 4.28K |
Sep 30
| |||
Form 4
| +96.77% | 1.14K |
$17.47 | $19,863.39 | 2.31K |
Jun 30
| |||
Form 4
|
∞
| 1.18K |
$16.88 | $19,834.00 | 1.18K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
II-VI INC (COHR) Snapshot price: $68.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$24.31 | -$44,432.50 | 30.55K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$26.16 | -$61,035.00 | 30.55K |
Jan 31
| |||
Form 4
| -12.59% | -4.40K |
$29.36 | -$129,169.92 | 30.55K |
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
$19.14 | -$25,279.60 | 34.95K |
Sep 8
| |||
Form 4
| +11.83% | 3.7K |
$21.67 | $80,092.32 | 34.95K |
Aug 20
| |||
Form 4
|
—
|
0
|
$18.57 | -$10,354.00 | 31.25K |
Mar 30
| |||
Form 4
| +16.76% | 4.49K |
$17.84 | $80,012.40 | 31.25K |
Aug 15
| |||
Form 4
| +27.18% | 5.72K |
—
|
—
| 26.77K |
Aug 16
| |||
Form 4
| +24.45% | 4.13K |
—
|
—
| 21.05K |
Aug 17
| |||
Form 4
| +34.21% | 4.31K |
—
|
—
| 16.91K |
Aug 18
| |||
Form 4
| +58.49% | 4.65K |
—
|
—
| 12.6K |
Aug 20
| |||
Form 4
| +8.90% | 325 |
$28.20 | $9,165.00 | 3.98K |
Jan 25
| |||
Form 4
| +117.91% | 1.98K |
—
|
—
| 3.65K |
Aug 21
| |||
Form 4
| +148.15% | 1K |
$23.60 | $23,600.00 | 1.68K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +237.50% | 475 |
$17.64 | $8,379.95 | 675 |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +100.00% | 100 |
$34.40 | $3,440.00 | 200 |
Oct 30
| |||
Form 4
|
∞
| 100 |
$30.06 | $3,006.00 | 100 |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +68.18% | 3K |
—
|
—
| 7.4K |
Feb 9
| |||
Form 4
| +131.58% | 2.5K |
—
|
—
| 4.4K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 1.9K |
—
|
—
| 1.9K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Renovacor, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.80K |
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +434.28% | 18.8K |
—
|
—
| 23.13K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |